Galmed Pharmaceuticals Ltd Shares Fall 5.2% Below Previous 52-Week Low - Market Mover
The shares fell 5.2% lower than its previous 52-week low of $1.72, with trading volume lower than its 30 day average
Jan 11, 2022 by Kwhen Finance Editors
Galmed Pharmaceuticals Ltd (GLMD) shares closed 5.2% lower than its previous 52 week low, giving the company a market cap of $47M. The stock is currently up 3.6% year-to-date, down 44.9% over the past 12 months, and down 53.5% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 89.1% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 0.7.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was under 30, indicating it may be underbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd | -13.5 | 3.6 | -44.9 | -72.8 | -1.2 |
| Dow Jones Industrial Average | -0.4 | -0.3 | 18.5 | -2.3 | 22.9 |
| S&P 500 Index | -0.1 | -1.9 | 23.9 | -3.6 | 27.3 |
| Health Care | 0.9 | -5.2 | 13.2 | -6.3 | 20.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by -246.4%
- The company's stock price performance over the past 12 months lags the peer average by 4.9%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Galmed Pharmaceuticals Ltd | GLMD | 0 | 3.6 | -44.9 | -72.8 | -1.2 |
| Peer Avg | N/A | 11.6 | -2.4 | -42.8 | -59.3 | 31.4 |
| Catalent Inc. | CTLT | 36.3 | -9.8 | 2.6 | -16.9 | 21.1 |
| Endo International plc | ENDP | 12.3 | -4.8 | -49.3 | -67.1 | 84.5 |
| Aerie Pharmaceuticals Inc | AERI | -2.2 | 9.7 | -44.8 | -63.9 | 15.1 |
| Evoke Pharma Inc | EVOK | 0 | -4.8 | -79.6 | -89.1 | 4.7 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: